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Crude extract of Buddleja asiatica Lour and its fractions, chloroform (F1), ethyl acetate (F2) and n++
butanol (F3) were evaluated for antibacterial, antifungal, antispasmodic and Ca antagonist activities.
The antibacterial activity was performed against 11 types of bacteria. The crude extract and fractions F2
and F3 exhibited significant activity, while F1 showed low activity in killing the Shigella flexenari,
Sternostoma boydi and Escherichia coli. In the rest bacteria, the crude extract and all the fractions (F1
to F3) revealed minimum to nil inhibitory effect. The fungicidal activity of the crude extract and all the
fractions (F1 to F3) was also performed against six different fungi. The crude extract and fractions F1
and F3 displayed significant activity, while fraction F2 showed moderate activity against Fusarium
solani. In the case of Microsporum canis, the crude extract and fraction F3 showed high activity but in
the other four fungi, the inhibition area exhibited optimum to nil activity in crude extract and all the
fractions (F1 to F3). In isolated rabbit jejunum preparations, B. asiatica crude extract caused
concentration-dependent (0.03 to 1.0 mg/ml) relaxation of spontaneous and high K+ (80 mM)-induced
contractions. The results indicate the antibacterial, antifungal, antispasmodic and Ca++ antagonist
potential of B. asiatica Lour.
Key words: Buddleja asiatica, antibacterial, antifungal, antispasmodic, Ca++ channel blocker.
INTRODUCTION
The genus Buddleja belonging to the family Scrophulariaceae, comprises approximately 100 species. In
Pakistan, it is represented by four species (Abdullah,
1974). This plant has been used medicinally in different
regions in the past and present. It has been used for skin
complaints (Pande et al., 2007) and as an abortifacient
(Nepal, 1970). A paste of its roots is used as a tonic
when mixed with rice water (Gage, 1904). This plant is
also used as a medicine for skin disease, abortion and as
a cure for loss of weight (Guerrero, 1921). Roots and leaves of this plant are employed to treat head tumor
(Hartwell, 1970). A fusion of roots is used in the treatment
of malaria (Reis and Von, 1973). The leaves of Buddleja
asiatica have a hypotensive effect on cats and dogs,
probably due to α-adrenoceptor blocking activity (Singh et

al., 1980). It is also reported that essential oil of the
leaves has in-vitro antifungal activities (Garg and Dengre,
1992). The flowers are used in the treatment of cystitis
and cold (Lee et al., 2008) and to treat edema (Zheng
and Xing, 2009). The extracts of B. asiatica also showed
strong cyclo-oxygenase inhibitory activities in elicited rat
peritoneal leukocytes (Liao et al., 1999). The ethnopharmacological and chemo-taxonomic importance of the
genus Buddleja prompted us to carry out investigation on
B. asiatica since no work has been carried out on the
antimicrobial activities of the plants and different
extracts/fractions. Also, in this investigation, the evidence
that B. asiatica exhibited spasmolytic effect, which is
mediated through Ca++ antagonist mechanism was shown.
MATERIALS AND METHODS

*Corresponding author. E-mail: Irshad_gomal@yahoo.com. Tel:
+92-966-7502359. Fax: +92-966-750255.

The whole plant of B. asiatica was collected from Banda Piran,
Siran valley, 2900 meters above the sea level, in the of District
Mansehra in October, 2007. It was identified by Professor Dr.
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Manzoor Ahmad, Plant Taxonomist, Department of Botany,
Government Degree College, Abbotabad, Pakistan. A voucher
specimen (Accession no. B-0015) has been deposited in the
herbarium.
Preparation of crude extract and fractions
The whole plant of Buddleja asiatica was shade-dried, ground to
powder (21 kg) and extracted with methanol (65 L) at room
temperature for seven days. The extraction was repeated thrice.
The combined methanolic extract was evaporated to obtain a
greenish gummy residue (522 g) which was divided into n-hexane
(63 g), chloroform (101 g), ethyl acetate (59 g), n-butanol (48 g) and
water (70 g) soluble fractions.
Fungal and bacterial strains were collected from the Institute of
Pharmaceutical Sciences, Faculty of Pharmacy, University of
Karachi, Karachi, Pakistan. Acetylcholine (ACh), dimethyl sulfoxide
(DMSO), sabouraud, glucose agar and imipenem were purchased
from Sigma Chemicals Co., St. Lous, USA. The solvents: n-butanol,
ethyl acetate, n-hexane, chloroform and methanol were from Merck,
Germany. Chemicals used for making physiological salt solutions:
potassium chloride, calcium chloride, glucose, magnesium chloride,
sodium bicarbonate, sodium dihydorgen phosphate and sodium
chloride were obtained from BDH Laboratories, England. All
chemicals were of analytical grade A.
Rabbits (1.5 to 2 kg) of either sex or local breed were used in this
study. They were housed at the Animal House of the Aga Khan
University, maintained at 23 to 25°C and given a standard diet and
tap water. Rabbits had free access to water, but food was
withdrawn 24 h prior to the experiment and killed by a blow on the
back of the head. Experiments performed complied with the rulings
of the Institute of Laboratory Animal Resources, Commission on
Life Sciences, National Research Council (1996) and were
approved by the Ethical Committee of the Aga Khan University.

isolated rabbit jejunum as described previously (Gilani et al., 1999).
Respective segments of 2 cm length were suspended in 10 ml of
Tyrode’s solution and bubbled with carbogen at 37°C. The
composition of Tyrode’s solution in mM was: KCl, 2.68, NaCl,
136.9, MgCl2, 1.05, NaHCO3, 11.90, NaH2 PO4, 0.42, CaCl2, 1.8 and
glucose, 5.55. A resting tension of 1 g was applied to each tissue
and kept constant throughout the experiment. Intestinal responses
were recorded isotonically using a Bioscience transducer and
Harvard oscillograph. Each tissue was allowed to equilibrate for at
least 30 min before addition of any drug, then stabilized with submaximal concentration of ACh (0.3 µM) and bath fluid was
subsequently replaced with normal Tyrode’s solution before starting
the experiment. Under these experimental conditions, jejunum
exhibited spontaneous rhythmic contractions, which allowed the
testing of the relaxant (spasmolytic) effect directly, without the use
of any agonist.
Determination of Ca++ antagonist action
To assess whether the antispasmodic effect of the plant materials is
mediated through calcium channel blockade, high K+ (80 mM) was
used to depolarize the preparations as described by Farre et al.
(1991). Addition of high K+ to the tissue bath produced a sustained
contraction. Relaxation of intestinal preparations by the plant
material, precontracted with K+, was expressed as percent of the
control response mediated by K+.

Statistical analysis
Data expressed were mean ± standard error of mean (SEM, n =
number of experiments).

RESULTS AND DISCUSSION
Antibacterial assay
The antibacterial activity was checked by the agar–well diffusion
method (Kavanagh, 1963). In this method, one loop full of 24 h old
culture containing approximately 104 to 106 CFU was spread on the
surface of Mueller-Hinton agar plates. Wells were dug in the
medium with the help of sterile metallic cork borer. Stock solutions
of the test samples (crude extract and fractions F1 to F3) with the
concentration of 1 mg/ml were prepared in DMSO and 100 µl
dilutions were added in their respective wells. The antibacterial
activity of crude extract and fractions (F1 to F3) were compared
with the standard drug imipenem which served as the positive
control.
Antifungal activity
The antifungal activity was determined by the agar well diffusion
method (Kavanagh, 1963). In this method, amphotericin and
miconazole were used as the standard drugs. The crude extract
and fractions (F1 to F3) were dissolved in DMSO (50 mg/ 5ml).
Sterile sabouraud’s dextrose agar medium (5 ml) was placed in a
test tube and inoculated with the sample solutions (400 µg/ml) and
kept in slanting position at room temperature overnight. The fungal
culture was then inoculated on the slant. The samples were
incubated for 7 days at 29°C and growth inhibition was observed.
Antispasmodic effect
The spasmolytic activity of the plant material was studied by using

Antibacterial activity of crude extract and various fractions
(F1 to F3) of B. asiatica L. was performed against 11
human pathogens including Escerichia coli, Bacillus
subtilis, Staphylococcus aureus, Shigella flexneri,
Sternostoma
boydi,
Pseudomonas
aeruginosa,
Salmonella typhi, Vibrio cholerae, Klebsiella pneumoniae,
Pseudomonas maltophilia and Mycobacterium leprae.
The results are shown in Table 1. The crude extract
displayed high to low activity in killing the S. boydi (56%),
E. coli (44%), S. flexneri (36%), S. aureus (25%), V.
cholera, (25%), B. subtilis (17%), M. leprae (13%) and P.
aeruginosa (10%) but no activity was seen against S.
typhi, K. pneumoniae and P. maltophilia. F1 was most
effective against S. flexenari (23 %) and S. boydi (16 %),
while less activity was seen in the case of inhibiting the
growth of P. aerigenosa (12 %) and E. coli. F1 was totally
ineffective against the rest of the bacteria. F2 exhibited
significant activity against S. boydi (67%) and E. coli
(44%), while low activity was seen in the killing of S.
flexneri (29%), P. aeruginosa (21%), S. aureus (18%), B.
subtilis (10%) and V. cholera (7%), but no activity was
observed in the rest of the bacteria. The fraction F3
revealed moderate to low activity in killing the S.
flexneri(58%), S. boydi (32%), V. cholera (29%), E. coli
(27%), P. aeruginosa (17%) and S. aureus (11%), and
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Table 1. Antibacterial activity of crude extracts and various fractions of Buddleja asiatica.

Bacteria

Z.I of standard drug (imipenem)

E. coli
B. subitiltis
S. aurous
S. boydi
S. flexenari
P. aerigenosa
S. typhi
V. cholera
K. pneumoniae
P. maltophilia

34
30
28
25
31
30
29
24
25
28

M. leprae

31

Crude extract
Z.I
Inh
15
44
5
17
7
25
14
56
11
36
3
10
--------6
25
----------------4

F1

F2

F3

Z.I
5
----2
4
7
4
-----------------

Inh
9
----7
16
23
12
-----------------

Z.I
15
3
5
16
9
2
----3
---------

Inh
44
10
18
67
29
21
----7
---------

Z.I
9
----3
8
18
5
----7
---------

Z.I
27
----11
32
58
17
----29
---------

3

10

-----

-----

2

7

13

Z.I = Zone of Inhibition in mm; Inh = Inhibition in %. The plates were inculcated at a concentration (mg/ml) of DMSO.

Table 2. Antifungal activity of the crude extracts and various fractions of B. asiatica.

Crude extract

F1

L.G

Inh

L.G

Inh

L.G

Inh

L.G

Inh

Name

MIC (µg/ml)

100
100

25
70

71
66

60
35

40
65

80
54

20
46

65
41

35
59

Amphotericin-B
Miconazole

30
105

C. albicans

100

100

-----

100

-----

100

-----

100

-----

Miconazole

20

T. longifusus

100

50

59

44

46

65

35

55

4

Miconazole

88

M .canis
C. glaberata

100
100

40
100

60
-----

80
100

20
-----

75
100

25
-----

35
100

65
-----

Miconazole
Miconazole

94
103

Fungi

Control L.G

A. flavus
F. solani

F2

F3

Standard drug

L.G= Linear growth in mm; Inh = Inhibition in %. The plates were inculcated at a concentration (mg/ml) of DMSO.

Table 3. Concentration-dependent inhibitory effect
of the crude extract of B. asiatica on spontaneous
contractions
of
isolated
rabbit
jejunum
preparations.

Concentration (mg/ml)

Inhibition (%)

0.03
0.1
0.3
1.0

5.7 ± 4.8
11.7 ± 9.3
38 ± 8.5
100

Values shown are mean ± SEM (n = 3).

did not show any activity against the others. These
results were compared with standard drug (imipenem)
which was more effective by showing maximum inhibition
zones (Table 1).
The fungicidal activity of the crude extract and various
fractions (F1 to F3) of B. asiatica was evaluated against
six fungi including Aspergillus flavus, Fusarium solani,
Candida lbicans, Trichophyton longifusus, Microsporum

canis and Candida glaberata. The results (Table 2)
indicated that the crude extract and fractions F1 and F3
displayed significant activity, while fraction F2 showed
moderate activity in killing F. solani. In the case of A.
flavus, and T. longifusus, the area of inhibition were
almost the same and exhibited very high activity in crude
extract, while in fractions F1 to F3, it showed optimum
activity. It was further observed that the crude extract and
fraction F3 showed high activity and fractions F1 and F2
revealed weak activity against M. canis. The crude
extract and fractions F1 to F3 remained totally ineffective
in killing C. albicans and C. glabrata.
B. asiatica crude extract inhibited spontaneous contractions at concentrations of 0.03, 0.1, 0.3 and 1.0 mg/ml by
5.7 ± 4.8, 11.7 ± 9.3, 38 ± 8.5 and 100% (mean ± SEM, n
= 3), respectively (Table 3), showing an antispasmodic
effect. The contraction of smooth muscle preparations
including rabbit jejunum was dependent upon an increase
++
in the cytoplasmic free Ca , which activates the
contractile elements (Karaki et al., 1997; Grasa et al.,
2004). The increase in intracellular Ca++ was due to either
++
influx via voltage dependant L-type Ca
channels
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Table 4. Concentration-dependent relaxant effect
of the crude extract of B. asiatica on K+-induced
contractions
of
isolated
rabbit
jejunum
preparations.

Concentration (mg/ml)
0.1
0.3
1.0

Relaxation (%)
6.7 ± 4.4
32.7 ± 9.8
100

Values shown are mean ± SEM, n = 3.

Table 5. High effective fractions amongst F1, F2 and F3 against various pathogens.

Pathogen

Common disease

Active fraction

Bacteria
E. coli (Gram-negative)
S. boydi (Gram-negative)
S. flexneri (Gram-negative)

Gastroenteritis , UTI, Meningitis in infants, septicaemia
Dysentery, Diarrhea
Diarrhea

F2
F3
F3

Fungi
F. solani
A. flavus
T. longifusus

Onychomycosis, nails infection, cornea, plant diseases
Cause allergy, liver carcinoma, brain infections, plant diseases
UTI infections, skin diseases

F1
F1
F1

(VDCs) or release from intracellular stores in the
sarcoplasmic reticulum. Periodic depolarization regulates
the spontaneous movements of intestine and at the
height of depolarization, the action potential appears as a
rapid influx of Ca++ via VDCs (Brading, 1981). The
inhibitory effect of the plant extract on spontaneous
movements of jejunum may be due to interference either
with the Ca++ release or with the Ca++ influx through
VDCs. In our earlier studies, we observed that the spasmolytic effect of the medicinal plants was usually
mediated through Ca++ channel blockade (Gilani et al.,
2007).
To see whether the spasmolytic effect of this plant is
also mediated via the same mechanism, the B. asiatica
was tested on high K+ (80 mM) induced contraction,
which was relaxed by the plant extract at 0.1, 0.3 and 1.0
mg/ml by 6.7 ± 4.4, 32.7 ± 9.8 and 100% (mean ± SEM, n
= 3), respectively (Table 4). At high concentration (> 30
mM), K+ is known to cause smooth muscle contractions
through opening of VDCs, thus allowing the influx of extra
cellular Ca++ and causes a contractile effect (Bolton,
1979), and a substance which causes inhibition of high
+
K -induced contraction is considered as an inhibitor of
Ca++ influx (Fleckenstein, 1977, Godfraind et al., 1986).
Conclusions
The results of this study indicate that ethyl acetate (F2)
and n-butanol (F3) fractions of B. asiatica are strong

inhibitor of Gram negative bacteria such as S. boydi, S.
flexneri and E. coli. Amongst all, the chloroform (F1)
fraction possessed outstanding antifungal activity against
A. flavus, F. solani and T. longifusus (Table 5). The crude
extracts also exhibited antispasmodic and Ca ++
antagonist effects. Thus, this study showed that the
medicinal plant B. asiatica contains antibacterial, antifungal, antispasmodic and Ca++ antagonist constituents.
The active fractions will be further investigated through
bioassay guided isolation to obtain the crude drugs and
active compounds.
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